SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

6 Jul 2022 07:00

RNS Number : 4196R
Numis Corporation PLC
06 July 2022
 

6 July 2022

Numis Corporation Plc ("Numis")

Trading Update

Stronger performance in Q3

 

Numis, the international investment bank, today issues a trading update in respect of the three-month period ended 30 June 2022.

Key highlights:

· Q3 revenue was in excess of £40m, which is ahead of the first half run-rate and reflects a strong improvement on the Q2 revenue performance 

· A favourable M&A environment has driven performance in investment banking and into H2, the M&A pipeline of both announced and possible transactions remains strong; equities and equity capital markets (ECM) continue to be affected by macro-themes

· European license granted, enabling greater interaction with EU-based institutional investors through Dublin office and facilitating future participation in EU ECM transactions

· While equity market and capital raising conditions continue to be challenging, the outlook remains in-line with market expectations for the full year

Favourable M&A environment drives performance in investment banking

The diversification of our investment banking activities continues to both enhance the resilience of the business and generate growth opportunities. 

Investment banking revenues have benefitted from a favourable M&A environment, which has led to increased bid activity across our corporate client base. Our strategic focus on strengthening our M&A capabilities and securing better roles and fees in these situations has continued to deliver positive results, and the outlook for M&A revenues remains encouraging.

In contrast, capital markets volumes remain subdued and whilst we have seen some recovery in activity during the third quarter, we expect macro-economic concerns to restrict deal volumes in the short term.

Equities continues to be affected by macro-themes

Equities revenues were marginally below the first half run-rate reflecting the cautious investor sentiment and market declines in the period, particularly across UK small and mid-caps. Despite these more difficult market conditions, our trading performance in Q3 was marginally better than the run rate of H1, helping to offset a quieter period for commissions. 

Dublin office to open in Q4

Our Dublin office has now received regulatory approval from the Central Bank of Ireland and we expect to commence trading during the final quarter. This will see us expand our capital markets reach to non-UK issuers; expand our leading equities platform to European institutional investors looking to gain exposure to UK equities; and further capitalise on working with high-growth private companies looking for growth capital.

Outlook - in-line with market expectations for the full year

Market conditions for equity markets and capital raising will likely remain challenging throughout the final quarter, however the M&A pipeline of both announced and possible transactions remains strong, and overall we continue to perform in line with market expectations for the full year.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

Contacts:

Numis Corporation:

Noreen Biddle Shah, Head of Corporate Communications 020 7260 1441

 

FTI Consulting LLP:

Edward Bridges 07768 216607

Daisy Hall 07807 298568

Grant Thornton UK LLP (Nominated Adviser): Philip Secrett 020 7728 2578Harrison Clarke 020 7184 4384

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution,

corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and

has offices in London, New York and Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVVVRUUUBRAR
Date   Source Headline
23rd Jan 20171:00 pmRNSDirectors' Dealing
19th Jan 20172:00 pmRNSDirectors' Dealing
18th Jan 201711:00 amRNSDirector's Dealing
12th Jan 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20179:51 amRNSAnnual Report and Annual General Meeting Notice
3rd Jan 201710:38 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20163:00 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 201611:05 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSPreliminary Results for the year ended 30 Sep 2016
1st Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20162:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20162:00 pmRNSDirector's Dealing
27th Oct 20161:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 201611:00 amRNSPurchase of shares in Close Period
3rd Oct 20167:00 amRNSTrading Update
14th Sep 20167:00 amRNSHolding(s) in Company
6th Sep 20169:45 amRNSDirector/PDMR Shareholding
5th Sep 20164:42 pmRNSGrant of Share Awards
22nd Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20163:11 pmRNSTransaction in Own Shares and Total Voting Rights
1st Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jul 201611:30 amRNSTransaction in Own Shares and Total Voting Rights
7th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20167:00 amRNSBoard Appointments
29th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
22nd Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 201611:47 amRNSDirector's Dealing
24th May 20163:16 pmRNSPosting of Interim Report
23rd May 20163:00 pmRNSHolding(s) in Company
19th May 20162:12 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 201610:00 amRNSTransfer of Shares from Treasury to EBT and TVR
13th May 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
9th May 20169:39 amRNSTransfer of Shares from Treasury to EBT and TVR
6th May 20167:01 amRNSBoard Changes
6th May 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.